Cost-effectiveness of adjuvant chemotherapy for high-risk stage II and stage III colon cancer in South Africa

Tan, S. X., Pumpalova, Y., Rogers, A. M., Bhatt, K., Herbst, C., Ruff, P., Neugut, A. I., & Hur, C. (2023). Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa. Cancer Medicine, 12(14), 15515–15529. Portico. https://doi.org/10.1002/cam4.6199
Authors:
Sarah Xinhui Tan
Yoanna Pumpalova
Alexandra M Rogers
Kishan Bhatt
Candice-Lee Herbst
Paul Ruff
Alfred I Neugut
Chin Hur
Affiliated Authors:
Sarah Xinhui Tan
Yoanna Pumpalova
Alexandra M Rogers
Kishan Bhatt
Alfred I Neugut
Chin Hur
Columbia Affiliation:
Subjects:
Colonic Neoplasms (MeSH)
Author Keywords:
adjuvant chemotherapy
cancer treatment
colon cancer
cost-effectiveness
south africa
elink
Publication Type:
Article
Unique ID:
10.1002/cam4.6199
PMID:
37318753
DOI:
10.1002/cam4.6199
Journal:
Cancer Medicine
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: